These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7727540)

  • 21. Fast and efficient characterization of an anti-gliadin monoclonal antibody epitope related to celiac disease using resin-bound peptides.
    Petersen NH; Hansen PR; Houen G
    J Immunol Methods; 2011 Feb; 365(1-2):174-82. PubMed ID: 21195715
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coeliac disease: in vivo toxicity of the putative immunodominant epitope.
    Fraser JS; Engel W; Ellis HJ; Moodie SJ; Pollock EL; Wieser H; Ciclitira PJ
    Gut; 2003 Dec; 52(12):1698-702. PubMed ID: 14633945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term cultivation of duodenal biopsies in patients with coeliac disease. Effect of gluten challenge and gliadin peptides.
    Kocna P; Fric P; Tlaskalová H; Krchnák V; Kasafírek E; Síová M; Czerkinsky C
    Adv Exp Med Biol; 1995; 371B():1367-70. PubMed ID: 7502819
    [No Abstract]   [Full Text] [Related]  

  • 24. Interactions among secretory immunoglobulin A, CD71, and transglutaminase-2 affect permeability of intestinal epithelial cells to gliadin peptides.
    Lebreton C; Ménard S; Abed J; Moura IC; Coppo R; Dugave C; Monteiro RC; Fricot A; Traore MG; Griffin M; Cellier C; Malamut G; Cerf-Bensussan N; Heyman M
    Gastroenterology; 2012 Sep; 143(3):698-707.e4. PubMed ID: 22750506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation of coeliac active peptide fractions from gliadin.
    Wieser H; Belitz HD; Ashkenazi A; Idar D
    Z Lebensm Unters Forsch; 1983; 176(2):85-94. PubMed ID: 6405556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of gliadin-derived peptides from bread and durum wheats on in vitro cultures of human cell lines. Implications for coeliac disease pathogenesis.
    Rocca E; Paganuzzi Stammati A; Zampaglioni F; Zucco F
    Toxicol Lett; 1983 May; 16(3-4):331-8. PubMed ID: 6857727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase.
    Arentz-Hansen H; Körner R; Molberg O; Quarsten H; Vader W; Kooy YM; Lundin KE; Koning F; Roepstorff P; Sollid LM; McAdam SN
    J Exp Med; 2000 Feb; 191(4):603-12. PubMed ID: 10684852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conformational studies of peptides corresponding to the coeliac-activating regions of wheat alpha-gliadin.
    Tatham AS; Marsh MN; Wieser H; Shewry PR
    Biochem J; 1990 Sep; 270(2):313-8. PubMed ID: 2400392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of common epitopes on gliadin, enterocytes, and calreticulin recognised by antigliadin antibodies of patients with coeliac disease.
    Krupicková S; Tucková L; Flegelová Z; Michalak M; Walters JR; Whelan A; Harries J; Vencovský J; Tlaskalová-Hogenová H
    Gut; 1999 Feb; 44(2):168-73. PubMed ID: 9895374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gliadin, glutenin or both? The search for the Holy Grail in coeliac disease.
    Howdle PD
    Eur J Gastroenterol Hepatol; 2006 Jul; 18(7):703-6. PubMed ID: 16772825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro toxicity of gluten peptides in coeliac disease assessed by organ culture.
    Shidrawi RG; Day P; Przemioslo R; Ellis HJ; Nelufer JM; Ciclitira PJ
    Scand J Gastroenterol; 1995 Aug; 30(8):758-63. PubMed ID: 7481543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IgA antibodies of coeliac disease patients recognise a dominant T cell epitope of A-gliadin.
    Bateman EA; Ferry BL; Hall A; Misbah SA; Anderson R; Kelleher P
    Gut; 2004 Sep; 53(9):1274-8. PubMed ID: 15306584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular hypersensitivity to a synthetic dodecapeptide derived from human adenovirus 12 which resembles a sequence of A-gliadin in patients with coeliac disease.
    Mantzaris GJ; Karagiannis JA; Priddle JD; Jewell DP
    Gut; 1990 Jun; 31(6):668-73. PubMed ID: 1696236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endocytotic segregation of gliadin peptide 31-49 in enterocytes.
    Zimmer KP; Fischer I; Mothes T; Weissen-Plenz G; Schmitz M; Wieser H; Büning J; Lerch MM; Ciclitira PC; Weber P; Naim HY
    Gut; 2010 Mar; 59(3):300-10. PubMed ID: 19654123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T lymphocyte responses to a synthetic peptide from the human intestinal adenovirus 12 in coeliac disease.
    Mantzaris GJ; Priddle JD; Jewell DP
    J Clin Lab Immunol; 1990 Feb; 31(2):75-9. PubMed ID: 1966988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mannan and oligomers of N-acetylglucosamine protect intestinal mucosa of celiac patients with active disease from in vitro toxicity of gliadin peptides.
    Auricchio S; De Ritis G; De Vincenzi M; Magazzù G; Maiuri L; Mancini E; Minetti M; Sapora O; Silano V
    Gastroenterology; 1990 Oct; 99(4):973-8. PubMed ID: 2394351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human genome search in celiac disease: mutated gliadin T-cell-like epitope in two human proteins promotes T-cell activation.
    Kumar R; Eastwood AL; Brown ML; Laurie GW
    J Mol Biol; 2002 Jun; 319(3):593-602. PubMed ID: 12054857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes.
    Moustakas AK; van de Wal Y; Routsias J; Kooy YM; van Veelen P; Drijfhout JW; Koning F; Papadopoulos GK
    Int Immunol; 2000 Aug; 12(8):1157-66. PubMed ID: 10917890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin.
    van de Wal Y; Kooy YM; van Veelen PA; Peña SA; Mearin LM; Molberg O; Lundin KE; Sollid LM; Mutis T; Benckhuijsen WE; Drijfhout JW; Koning F
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10050-4. PubMed ID: 9707598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paracellular versus transcellular intestinal permeability to gliadin peptides in active celiac disease.
    Ménard S; Lebreton C; Schumann M; Matysiak-Budnik T; Dugave C; Bouhnik Y; Malamut G; Cellier C; Allez M; Crenn P; Schulzke JD; Cerf-Bensussan N; Heyman M
    Am J Pathol; 2012 Feb; 180(2):608-15. PubMed ID: 22119716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.